The mechanism is straightforward: GLP-1 agonists reduce activation in your hypothalamus and gut-brain axis, lowering hunger signals and slowing gastric emptying
People who were prescribed Wegovy and suffered serious side effects not listed on the label may be able to file a Wegovy lawsuit if they can prove their medical issue was related to Wegovy use
There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
Mirmira, MD, PhD, professor of medicine
At the same time, because generic drugs are not under patent protection, they represent an easier entrance for entities to both manufacture and sell at a competitive cost, especially if there exists a large pricing spread due to other market dynamics